Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tscan Therapeutics Inc (NQ: TCRX ) 5.350 -0.260 (-4.63%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Tscan Therapeutics Inc < Previous 1 2 3 4 5 Next > 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 30, 2023 Via Benzinga Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket May 30, 2023 Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 30, 2023 It's time for a look at the biggest pre-market stock movers on Tuesday morning with all the details traders need to know about! Via InvestorPlace TScan Therapeutics: Q1 Earnings Insights May 10, 2023 Via Benzinga TScan Therapeutics Inc. (NASDAQ: TCRX) Near the Top of Equities by Percentage Gain on 5/9 May 09, 2023 Via Investor Brand Network 12 Health Care Stocks Moving In Monday's Intraday Session May 29, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 29, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 26, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 26, 2023 It's time for another dive into the biggest pre-market stock movers as we check out what's happening this morning on Friday! Via InvestorPlace TScan Therapeutics Announces Pricing of $140 Million Public Offering May 26, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire TScan Therapeutics Announces Launch of Proposed Public Offering May 25, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors May 24, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire TScan Therapeutics Shares Fall After Preliminary Data Highlight In Leukemia Patients May 17, 2023 TScan Therapeutics Inc (NASDAQ: TCRX) announced a poster presentation highlighting preliminary data from the Phase 1 umbrella clinical trial evaluating TSC-100 and TSC-101 targeting minor... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 17, 2023 Via Benzinga TScan Therapeutics Presents Preliminary Phase 1 Clinical Results on TSC-100 and TSC-101 at the American Society of Gene & Cell Therapy 26th Annual Meeting May 17, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session May 10, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 10, 2023 Via Benzinga Top 5 Health Care Stocks That May Collapse In Q2 May 10, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update May 10, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire Gold Edges Higher; PayPal Shares Tumble Despite Upbeat Earnings May 09, 2023 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 50 points on Tuesday. The Dow traded down 0.01% to 33,616.00 while the NASDAQ fell 0.43% to... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 09, 2023 Via Benzinga Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 09, 2023 Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. Via Benzinga Crude Oil Down 1%; Under Armour Earnings Top Views May 09, 2023 U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 50 points on Tuesday. The Dow traded down 0.07% to 33,593.48 while the NASDAQ fell 0.52% to 12,193.35. The S&P... Via Benzinga Why Are TScan Therapeutics Shares Are Shooting Higher Today May 09, 2023 Amgen Inc (NASDAQ: AMGN) and TScan Therapeutics Inc (NASDAQ: TCRX) announced a multi-year collaboration to use TScan's proprietary target discovery platform, TargetScan, to identify the antigens recog Via Benzinga TScan Therapeutics (NASDAQ: TCRX) and Amgen (NASDAQ: AMGN) Join Forces to Battle Crohn’s Disease May 09, 2023 TScan Therapeutics, Inc. (NASDAQ: TCRX) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development Via Spotlight Growth 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 09, 2023 Via Benzinga Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease May 09, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the American Society of Gene and Cell Therapy 26th Annual Meeting May 02, 2023 Company to host a virtual event to discuss highlights from its Phase 1 umbrella trial of TSC-100 and TSC-101 on Wednesday, May 17, 2023, at 5:30 p.m. ET From TScan Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session May 02, 2023 Via Benzinga TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors April 10, 2023 From TScan Therapeutics, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.